Osteoporosis screening recommendations may miss two-thirds of women aged 50 to 64

by Enrique Rivero

Women who are 65 and older routinely undergo bone-density testing to screen for osteoporosis. But for those between the ages of 50 and 64, it has been unclear who should be screened.

Researchers sought to determine how well the current screening strategy recommended by the U.S. Preventive Services Task Force—the independent expert panel appointed by the to review and recommend various screenings—would perform in identifying candidates in this age range for screening.

Using health data on women ages 50–64 from the Women's Health Initiative study, the researchers found that the current strategy would identify only 34 percent of women who actually had bone-mineral density in the osteoporosis range.

The U.S. Preventive Services Task Force strategy may not identify the majority of women in the 50–64 age group who would be potential candidates for therapy. As a result, following the strategy may lead to missed opportunities to decrease in at-risk women.

More information: "Osteoporosis Screening in Postmenopausal Women 50–64 Years-Old: Comparison of U.S. Preventive Services Task Force Strategy and Two Traditional Strategies in the Women's Health Initiative." Carolyn J. Crandall MD, Joseph Larson , Margaret L. Gourlay MD, et al. Journal of Bone and Mineral Research, 2014. DOI: 10.1002/jbmr.2174

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Long wait yet for Ebola vaccine: experts

10 minutes ago

It will be months, at least, before a vaccine becomes available to tackle Ebola, experts said Thursday as researchers reported success in early, safety tests with a leading candidate.

Sierra Leone to miss target for beating Ebola: UN

1 hour ago

The United Nations' Ebola response mission admitted Thursday it was going to miss its target for beating the deadly epidemic in Sierra Leone due to a chronic shortage of hospital beds.

Global Ebola toll rises to 5,689: WHO

5 hours ago

The World Health Organization said Thursday that the global death toll from the Ebola virus had increased to 5,689 out of a total of 15,935 cases of infection, mainly in western Africa.

Ebola vaccine promising in first human trials

16 hours ago

Researchers say they're a step closer to developing an Ebola vaccine, with a Phase 1 trial showing promising results, but it will be months at the earliest before it can be used in the field.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.